Safety and tolerability of amustaline/glutathione pathogen‐reduced red blood cells in neonatal rats
Key Points
The study aims to evaluate the safety and tolerability of amustaline/glutathione pathogen-reduced red blood cells in neonatal rats.
Conducted a neonatal rat study to assess transfusion safety
Analyzed the tolerability of amustaline/GSH PR-RBCs
Amustaline/GSH PR-RBCs showed acceptable safety profiles in neonatal rats, indicating potential for pediatric use.
Abstract
The neonatal rat study demonstrates the safety and tolerability of amustaline/GSH PR-RBCs for transfusion and supports clinical use in pediatric patients.